- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 491/18 - Systèmes pontés
Détention brevets de la classe C07D 491/18
Brevets de cette classe: 264
Historique des publications depuis 10 ans
|
20
|
21
|
20
|
14
|
16
|
20
|
18
|
25
|
26
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3741 |
11 |
| Novartis AG | 10904 |
7 |
| Pfizer Inc. | 3367 |
7 |
| The Trustees of Columbia University in the City of New York | 3558 |
5 |
| Nippon Chemiphar Co., Ltd. | 228 |
5 |
| Case Western Reserve University | 1799 |
4 |
| Hangzhou Bensheng Pharmaceutical Co., Ltd. | 16 |
4 |
| Revolution Medicines, Inc. | 229 |
4 |
| TP Therapeutics, Inc., AKA Turning Point Therapeutics | 9 |
4 |
| Turning Point Therapeutics, Inc. | 99 |
4 |
| Merck Patent GmbH | 5850 |
3 |
| Takeda Pharmaceutical Company Limited | 2704 |
3 |
| AM Chemicals LLC | 10 |
3 |
| Arkema France | 3987 |
3 |
| Blue Oak Pharmaceuticals, Inc. | 7 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 820 |
3 |
| The Walter and Eliza Hall Institute of Medical Research | 164 |
3 |
| Wuhan Institute of Virology, Chinese Academy of Sciences | 47 |
3 |
| MSD R & D (China) Co. LTD. | 54 |
3 |
| Janssen Sciences Ireland Unlimited Company | 395 |
3 |
| Autres propriétaires | 179 |